The cancer-associated membrane glycoprotein dysadherin facilitates the invasion of tumor cells into the Matrigel in estrogen receptor (ER)-negative breast tumor cells through controlling CCL2 production in vitro and lung metastases in an in vivo animal model. This evidence concerns the gene FXYD5 and neoplasm.